Marksans Pharma Limited (MARKSANS.NS)

INR 314.2

(-1.83%)

Eps Summary of Marksans Pharma Limited

Marksans Pharma Limited's latest annual eps in 2023 was 6.92 INR , up 7.96% from previous year.
Marksans Pharma Limited's latest quarterly eps in 2024 Q1 was 1.96 INR , up 13.29% from previous quarter.
Marksans Pharma Limited reported an annual eps of 6.41 INR in 2022, up 42.13% from previous year.
Marksans Pharma Limited reported an annual eps of 4.51 INR in 2021, down -21.7% from previous year.
Marksans Pharma Limited reported a quarterly eps of 1.84 INR for 2023 Q2, up 21.05% from previous quarter.
Marksans Pharma Limited reported a quarterly eps of 1.84 INR for 2023 Q3, down 0.0% from previous quarter.

Annual Eps Chart of Marksans Pharma Limited (2023 - 2004)

Historical Annual Eps of Marksans Pharma Limited (2023 - 2004)

Year	Eps	Eps Growth
2023	6.92 INR	7.96%
2022	6.41 INR	42.13%
2021	4.51 INR	-21.7%
2020	5.76 INR	101.4%
2019	2.86 INR	45.18%
2018	1.97 INR	146.25%
2017	0.80 INR	263.64%
2016	0.22 INR	-88.54%
2015	1.92 INR	-28.09%
2014	2.67 INR	42.78%
2013	1.87 INR	57.14%
2012	1.19 INR	124.49%
2011	-4.86 INR	19.93%
2010	-6.07 INR	-2148.15%
2009	-0.27 INR	-17.39%
2008	-0.23 INR	-153.49%
2007	0.43 INR	126.32%
2006	0.19 INR	-70.31%
2005	0.64 INR	28.0%
2004	0.50 INR	0.0%

Year	Eps	Eps Growth
2024 Q1	1.96 INR	13.29%
2023 Q2	1.84 INR	21.05%
2023 Q3	1.84 INR	0.0%
2023 Q1	1.52 INR	-22.84%
2023 FY	- INR	7.96%
2023 Q4	1.73 INR	-5.98%
2022 Q4	1.97 INR	25.48%
2022 Q2	1.52 INR	4.11%
2022 FY	- INR	42.13%
2022 Q1	1.46 INR	102.78%
2022 Q3	1.57 INR	3.29%
2021 Q3	1.20 INR	8.11%
2021 Q1	1.53 INR	-20.31%
2021 FY	- INR	-21.7%
2021 Q2	1.11 INR	-27.45%
2021 Q4	0.72 INR	-40.0%
2020 Q3	1.42 INR	17.36%
2020 Q2	1.21 INR	0.83%
2020 Q1	1.20 INR	17.65%
2020 FY	- INR	101.4%
2020 Q4	1.92 INR	35.21%
2019 Q3	0.71 INR	12.7%
2019 Q1	0.52 INR	126.09%
2019 Q4	1.02 INR	43.66%
2019 Q2	0.63 INR	21.15%
2019 FY	- INR	45.18%
2018 Q4	0.23 INR	-61.67%
2018 Q3	0.60 INR	25.0%
2018 Q2	0.48 INR	-17.24%
2018 FY	- INR	146.25%
2018 Q1	0.58 INR	441.18%
2017 FY	- INR	263.64%
2017 Q4	-0.17 INR	-141.46%
2017 Q3	0.41 INR	78.26%
2017 Q2	0.23 INR	-30.3%
2017 Q1	0.33 INR	526.36%
2016 Q3	0.24 INR	1100.0%
2016 Q2	0.02 INR	-81.82%
2016 Q1	0.11 INR	178.57%
2016 Q4	-0.08 INR	-132.25%
2016 FY	- INR	-88.54%
2015 Q2	0.85 INR	10.39%
2015 FY	- INR	-28.09%
2015 Q3	0.44 INR	-48.24%
2015 Q4	-0.14 INR	-131.82%
2015 Q1	0.77 INR	28.33%
2014 Q1	0.66 INR	164.0%
2014 Q4	0.60 INR	-16.67%
2014 Q3	0.72 INR	-11.11%
2014 FY	- INR	42.78%
2014 Q2	0.81 INR	22.73%
2013 Q4	0.25 INR	-56.9%
2013 Q3	0.58 INR	11.54%
2013 Q1	0.49 INR	-49.48%
2013 FY	- INR	57.14%
2013 Q2	0.52 INR	6.12%
2012 Q1	-0.46 INR	0.0%
2012 FY	- INR	124.49%
2012 Q4	0.97 INR	361.9%
2012 Q3	0.21 INR	-44.74%
2012 Q2	0.38 INR	182.61%
2011 FY	- INR	19.93%
2010 FY	- INR	-2148.15%
2009 FY	- INR	-17.39%
2008 FY	- INR	-153.49%
2007 FY	- INR	126.32%
2006 FY	- INR	-70.31%
2005 FY	- INR	28.0%
2004 FY	- INR	0.0%

Peer Eps Comparison of Marksans Pharma Limited

Name	Eps	Eps Difference
Abbott India Limited	565.30 INR	98.776%
Cipla Limited	51.05 INR	86.445%
Gland Pharma Limited	46.90 INR	85.245%
GlaxoSmithKline Pharmaceuticals Limited	34.83 INR	80.132%
Kopran Limited	10.57 INR	34.532%
NGL Fine-Chem Limited	66.88 INR	89.653%
Pfizer Limited	120.51 INR	94.258%
Sanofi India Limited	261.78 INR	97.357%
SMS Pharmaceuticals Limited	5.89 INR	-17.487%
TTK Healthcare Limited	44.47 INR	84.439%